Predicting severe jaundice in newborns
Part of Genetic & congenital clinical trials.
This trial tests a scoring tool called BIND to see how well it predicts which newborns with severe jaundice need intensive treatment. If you have a baby under 28 days old with severe jaundice that might need a blood transfusion, this study could apply to them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is less than 28 days old
- Your baby has severe jaundice that needs very strong light therapy or might need a blood exchange transfusion
- Your baby does not have any abnormal brain or nerve signs from other illnesses (like lack of oxygen at birth or muscle problems)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares different blood-bilirubin (jaundice) thresholds for treating very premature babies (born before 30 weeks) in the NICU. It aims to find the safest way to manage jaundice to prevent complications.
This study checks whether a device that reads bilirubin through the skin can be used to guide treatment with newborn phototherapy (special light). It may help babies with jaundice get the right monitoring and light treatment safely.
This study looks at newborn babies treated with light therapy for jaundice to find out who might need extra monitoring after treatment stops. It aims to help doctors predict if jaundice will come back within 48 hours.
This trial tests different ways to give light therapy to newborns with jaundice. It compares different approaches to see which is best, and may help parents understand the most effective treatment for their baby.
This trial tests if giving a zinc or bile acid medicine alongside light therapy helps break down jaundice faster in newborns. It could shorten treatment time for babies who need phototherapy in their first week of life.
This trial uses a special breath test (ETCOc) to measure jaundice in newborns, aiming to improve diagnosis and treatment. It may help doctors decide when treatment is needed.
Hear when a new Neonatal Hyperbilirubinemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.